Antisense oligonucleotides in lung cancer.
Pujol
Jean-Louis
JL
Montpellier Academic Hospital, Montpellier, France.
Jacot
William
W
D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000628:therapy*; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D054735:Phosphorothioate Oligonucleotides; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects; D013873:Thionucleotides / Q000627:therapeutic use*; D018631:ras Proteins / Q000037:antagonists & inhibitors* / Q000502:physiology
C122000:ISIS 2503; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense; D054735:Phosphorothioate Oligonucleotides; D013873:Thionucleotides; C108494:ISIS 3521; D011493:Protein Kinase C; D018631:ras Proteins